Biogen Inc Shs Cert Deposito Arg Repr 1/13 ShBiogen Inc Shs Cert Deposito Arg Repr 1/13 ShBiogen Inc Shs Cert Deposito Arg Repr 1/13 Sh

Biogen Inc Shs Cert Deposito Arg Repr 1/13 Sh

No trades
See on Supercharts

Key facts today


Biogen's shares fell 3% after Needham analyst Ami Fadia maintained a 'Hold' rating and unchanged price target, disappointing investors who expected a more positive outlook.
Analyze the impactAnalyze the impact
Market capitalization
‪27.85 T‬ARS
‪1.49 T‬ARS
‪8.49 T‬ARS
Beta (1Y)
0.18

About Biogen Inc.


CEO
Christopher A. Viehbacher
Website
Headquarters
Cambridge
Founded
1978
ISIN
ARBCOM4601A8
FIGI
BBG00PCCBPX0
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

Check out other big names from the same industry as BIIB.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
BIIB6071255
Biogen Inc. 6.45% 15-MAY-2055
Yield to maturity
Maturity date
May 15, 2055
BIIB6071254
Biogen Inc. 5.05% 15-JAN-2031
Yield to maturity
Maturity date
Jan 15, 2031
BIIB5133379
Biogen Inc. 3.25% 15-FEB-2051
Yield to maturity
Maturity date
Feb 15, 2051
BIIB5133378
Biogen Inc. 3.25% 15-FEB-2051
Yield to maturity
Maturity date
Feb 15, 2051
BIIB6071069
Biogen Inc. 5.75% 15-MAY-2035
Yield to maturity
Maturity date
May 15, 2035
BIIB4981508
Biogen Inc. 3.15% 01-MAY-2050
Yield to maturity
Maturity date
May 1, 2050
BIIB4981506
Biogen Inc. 2.25% 01-MAY-2030
Yield to maturity
Maturity date
May 1, 2030
US9062XAD5
Biogen Inc. 5.2% 15-SEP-2045
Yield to maturity
Maturity date
Sep 15, 2045

See all BIIB bonds 

Curated watchlists where BIIB is featured.